Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer
Kevin Chih‐Yang Huang(China Medical University), K. S. Clifford Chao(China Medical University)
Cited by 115
Related Papers
Engineered sTRAIL-armed MSCs overcome STING deficiency to enhance the therapeutic efficacy of radiotherapy for immune checkpoint blockade
|Cell Death and Disease|2022|47
DNMT1 constrains IFNβ-mediated anti-tumor immunity and PD-L1 expression to reduce the efficacy of radiotherapy and immunotherapy
|OncoImmunology|2021|41
Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation
|Cancer Immunology Immunotherapy|2023|30